Prognostic Significance of Residual Acute Myeloid Leukemia in Bone Marrow Samples Taken Prior to Allogeneic Hematopoietic Cell Transplantation.

about

Prognostic Significance of Residual Acute Myeloid Leukemia in Bone Marrow Samples Taken Prior to Allogeneic Hematopoietic Cell Transplantation.

Item

http://www.wikidata.org/entity/Q40370775

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Prognostic Significance of Res ...... opoietic Cell Transplantation.

@en

type

Item

label

Prognostic Significance of Res ...... opoietic Cell Transplantation.

@en

prefLabel

Prognostic Significance of Res ...... opoietic Cell Transplantation.

@en

P1476

Prognostic Significance of Res ...... opoietic Cell Transplantation.

@en

P2093

Alexandra E Kovach

http://www.w3.org/2001/XMLSchema#string

Amir T Fathi

http://www.w3.org/2001/XMLSchema#string

Andrew M Brunner

http://www.w3.org/2001/XMLSchema#string

Robert P Hasserjian

http://www.w3.org/2001/XMLSchema#string

Yi-Bin Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Defining minimal residual disease in acute myeloid leukemia: which platforms are ready for "prime time"?

Assessment of Minimal Residual Disease in Standard-Risk AML.

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Bone marrow necrosis: clinicopathologic analysis of 20 cases and review of the literature.

Effect of complete remission and responses less than complete remission on survival in acute myeloid leukemia: a combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M. D. Anderson Cancer Center Study

Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006.

Significance of persistent cytogenetic abnormalities on myeloablative allogeneic stem cell transplantation in first complete remission.

Donor compatibility and performance status affect outcome of allogeneic haematopoietic stem cell transplant in patients with relapsed or refractory acute myeloid leukaemia.

Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia.

P304

50-59

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/AJCP/AQW203

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

147

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28108471

http://www.w3.org/2001/XMLSchema#string